| [1] |
成军, 窦攀, 段盛林, 等. 中国超重/肥胖医学营养治疗指南(2021) [J]. 中国医学前沿杂志(电子版), 2021, 13 (11): 1-55.
|
| [2] |
Phelps NH, Singleton RK, Zhou B, et al. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults [J]. The Lancet, 2024: S0140673623027502.
|
| [3] |
Dent J. Epidemiology of gastro-oesophageal reflux disease: a systematic review [J]. Gut, 2005, 54(5): 710-717.
|
| [4] |
Vakil N, Van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus [J]. The American Journal of Gastroenterology, 2006, 101(8): 1900-1920.
|
| [5] |
El-Serag HB, Graham DY, Satia J A, et al. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis [J]. The American Journal of Gastroenterology, 2005, 100(6): 1243-1250.
|
| [6] |
Stein DJ, El‐Serag HB, Kuczynski J, et al. The association of body mass index with Barrett’s oesophagus [J]. Alimentary Pharmacology & Therapeutics, 2005, 22(10): 1005-1010.
|
| [7] |
Nimptsch K, Steffen A, Pischon T. Obesity and Oesophageal Cancer [M]//Pischon T, Nimptsch K. Obesity and Cancer: Vol. 208. Cham: Springer International Publishing, 2016: 67-80.
|
| [8] |
Nam SY, Choi IJ, Ryu KH, et al. Abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in men and women [J]. Gastroenterology, 2010, 139(6): 1902-1911.e2.
|
| [9] |
Stephens T W, Basinski M, Bristow P K, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product [J]. Nature, 1995, 377(6549): 530-532.
|
| [10] |
Landecho M F, Tuero C, Valentí V, et al. Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk [J]. Nutrients, 2019, 11(11): 2664.
|
| [11] |
Park H K, Ahima R S. Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism [J]. Metabolism, 2015, 64(1): 24-34.
|
| [12] |
Woods S C, Schwartz M W, Baskin D G, et al. Food intake and the regulation of body weight [J]. Annual Review of Psychology, 2000, 51(1): 255-277.
|
| [13] |
Banks W A, DiPalma C R, Farrell C L. Impaired transport of leptin across the blood-brain barrier in obesity [J]. Peptides, 1999, 20(11): 1341-1345.
|
| [14] |
Brennan AM, Mantzoros CS. Drug Insight: the role of leptin in human physiology and pathophysiology--emerging clinical applications [J]. Nature Clinical Practice Endocrinology & Metabolism, 2006, 2(6): 318-327.
|
| [15] |
Abdelkader NA, Montasser IF, Bioumy EE, et al. Impact of anthropometric measures and serum leptin on severity of gastroesophageal reflux disease [J]. Diseases of the Esophagus, 2015, 28(7): 691-698.
|
| [16] |
Murata T, Asanuma K, Ara N, et al. Leptin aggravates reflux esophagitis by increasing tissue levels of macrophage migration inhibitory factor in rats [J]. The Tohoku Journal of Experimental Medicine, 2018, 245(1): 45-53.
|
| [17] |
Hotta K, Funahashi T, Bodkin N L, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys [J]. Diabetes, 2001, 50(5): 1126-1133.
|
| [18] |
Greer KB, Falk GW, Bednarchik B, et al. Associations of serum adiponectin and leptin with barrett’s esophagus [J]. Clinical Gastroenterology and Hepatology, 2015, 13(13): 2265-2272.
|
| [19] |
El-Serag HB, Tran T, Richardson P, et al. Anthropometric correlates of intragastric pressure [J]. Scandinavian Journal of Gastroenterology, 2006, 41(8): 887-891.
|
| [20] |
Del Grande LDM, Herbella FAM, Patti MG. The role of the transdiaphragmatic pressure gradient (TGP) in the Pathophysiology of Proximal Reflux [J]. Journal of Gastrointestinal Surgery, 2021, 25(2): 351-356.
|
| [21] |
Becker V. Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors [J]. World Journal of Gastroenterology, 2014, 20(14): 4017.
|
| [22] |
Küper MA, Kramer KM, Kischniak A, et al. Dysfunction of the lower esophageal sphincter and dysmotility of the tubular esophagus in morbidly obese patients [J]. Obesity Surgery, 2009, 19(8): 1143-1149.
|
| [23] |
Wu JC, Mui L, Cheung CM, et al. Obesity is associated with increased transient lower esophageal sphincter relaxation [J]. Gastroenterology, 2007, 132(3): 883-889.
|
| [24] |
Franzén T. Is the severity of gastroesophageal reflux dependent on hiatus hernia size? [J]. World Journal of Gastroenterology, 2014, 20(6): 1582.
|
| [25] |
Sawada A, Rogers B, Visaggi P, et al. Effect of hiatus hernia on reflux patterns and mucosal integrity in patients with non-erosive reflux disease [J]. Neurogastroenterology & Motility, 2022, 34(11): e14412.
|
| [26] |
Iwakiri K, Tanaka Y, Hayashi Y, et al. Association between reflux esophagitis and/or hiatus hernia and gastric mucosal atrophy level in Japan [J]. Journal of Gastroenterology and Hepatology, 2007, 22(12): 2212-2216.
|
| [27] |
Yen HH, Tseng PH, Shih MC, et al. Derangement of esophageal anatomy and motility in morbidly obese patients: a prospective study based on high-resolution impedance manometry [J]. Surgery for Obesity and Related Diseases, 2020, 16(12): 2006-2015.
|
| [28] |
Kleidi E, Theodorou D, Albanopoulos K, et al. The effect of laparoscopic sleeve gastrectomy on the antireflux mechanism: can it be minimized? [J]. Surgical Endoscopy, 2013, 27(12): 4625-4630.
|
| [29] |
Namikawa T, Kitagawa H, Okabayashi T, et al. Roux-en-Y reconstruction is superior to billroth I reconstruction in reducing reflux esophagitis after distal gastrectomy: special relationship with the angle of his [J]. World Journal of Surgery, 2010, 34(5): 1022-1027.
|
| [30] |
Zhang C, Hu ZW, Yan C, et al. Nissen fundoplication vs proton pump inhibitors for laryngopharyngeal reflux based on pH-monitoring and symptom-scale [J]. World Journal of Gastroenterology, 2017, 23(19): 3546.
|
| [31] |
Arterburn DE, Telem DA, Kushner RF, et al. Benefits and Risks of Bariatric Surgery in Adults: A Review [J]. JAMA, 2020, 324(9): 879.
|
| [32] |
Ivezaj V, Barnes RD, Cooper Z, et al. Loss-of-control eating after bariatric/sleeve gastrectomy surgery: Similar to binge-eating disorder despite differences in quantities [J]. General Hospital Psychiatry, 2018, 54: 25-30.
|
| [33] |
Felsenreich DM, Bichler C, Langer FB, et al. Sleeve Gastrectomy: Surgical Technique, Outcomes, and Complications [J]. Surgical Technology International, 2020, 36: 63-69.
|
| [34] |
Yeung KTD, Penney N, Ashrafian L, et al. Does Sleeve Gastrectomy Expose the Distal Esophagus to Severe Reflux? A Systematic Review and Meta-analysis [J]. Annals of Surgery, 2020, 271(2): 257-265.
|
| [35] |
Lim CH, Lee PC, Lim E, et al. Correlation Between Symptomatic Gastro-Esophageal Reflux Disease (GERD) and Erosive Esophagitis (EE) Post-vertical Sleeve Gastrectomy (VSG) [J]. Obesity Surgery, 2019, 29(1): 207-214.
|
| [36] |
Popescu AL, Ioniţa-Radu F, Jinga M, et al. Laparoscopic sleeve gastrectomy and gastroesophageal reflux [J]. Romanian Journal of Internal Medicine, 2018, 56(4): 227-232.
|
| [37] |
中国医师协会外科医师分会肥胖和糖尿病外科医师委员会. 腹腔镜Roux-en-Y胃旁路术规范化手术操作指南(2019版) [J/CD]. 中华肥胖与代谢病电子杂志, 2019, 5 (2): 63-69.
|
| [38] |
Chiappetta S, Stier C, Scheffel O, et al. Mini/One Anastomosis Gastric Bypass Versus Roux-en-Y Gastric Bypass as a Second Step Procedure After Sleeve Gastrectomy-a Retrospective Cohort Study [J]. Obesity Surgery, 2019, 29(3): 819-827.
|
| [39] |
Nadaleto BF, Herbella FAM, Patti MG. Gastroesophageal reflux disease in the obese: Pathophysiology and treatment [J]. Surgery, 2016, 159(2): 475-486.
|
| [40] |
Gorodner V, Matucci A, Solé L, et al. Does Roux-en-Y gastric bypass really cure gastroesophageal reflux disease? analysis of objective data [J]. J Laparoendosc Adv Surg Tech A, 2022, 32(2): 103-110.
|
| [41] |
Carbajo MA, Luque-de-León E, Jiménez JM, et al. Laparoscopic one-anastomosis gastric bypass: technique, results, and long-term follow-up in 1200 patients [J]. Obesity Surgery, 2017, 27(5): 1153-1167.
|
| [42] |
Chiappetta S, Weiner R. Evidence of the Mini-/One-anastomosis-gastric-Bypass for being a standard procedure in obesity and metabolic surgery [J]. Der Chirurg, 2018, 89(8): 589-596.
|
| [43] |
Esparham A, Ahmadyar S, Zandbaf T, et al. Does one-anastomosis gastric bypass expose patients to gastroesophageal reflux: a systematic review and meta-analysis [J]. Obesity Surgery, 2023, 33(12): 4080-4102.
|
| [44] |
Tjon JA, Pe M, Soscia J, et al. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease [J]. Pharmacotherapy, 2013, 33(9): 956-971.
|
| [45] |
f Scarpignato C, Gatta L, Zullo A, et al. Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression [J]. BMC Medicine, 2016, 14(1): 179.
|
| [46] |
Sugano K. Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date [J]. Therapeutic Advances in Gastroenterology, 2018, 11: 1756283X1774577.
|
| [47] |
Leowattana W, Leowattana T. Potassium-competitive acid blockers and gastroesophageal reflux disease [J]. World Journal of Gastroenterology, 2022, 28(28): 3608-3619.
|
| [48] |
Li S, Shi S, Chen F, et al. The effects of baclofen for the treatment of gastroesophageal reflux disease: a meta-analysis of randomized controlled trials [J]. Gastroenterology Research and Practice, 2014, 2014: 1-8.
|
| [49] |
Iwakiri K, Fujiwara Y, Manabe N, et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021 [J]. Journal of Gastroenterology, 2022, 57(4): 267-285.
|
| [50] |
Koyyada A. Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations [J]. Therapies, 2021, 76(1): 13-21.
|
| [51] |
Franciosa M, Triadafilopoulos G, Mashimo H. Stretta Radiofrequency Treatment for GERD: A Safe and Effective Modality [J]. Gastroenterology Research and Practice, 2013, 2013: 1-8.
|
| [52] |
Fass R, Cahn F, Scotti DJ, et al. Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease [J]. Surgical Endoscopy, 2017, 31(12): 4865-4882.
|
| [53] |
Rodríguez De Santiago E, Albéniz E, Estremera-Arevalo F, et al. Endoscopic anti-reflux therapy for gastroesophageal reflux disease [J]. World Journal of Gastroenterology, 2021, 27(39): 6601-6614.
|
| [54] |
Hu HQ, Li HK, Xiong Y, et al. Peroral endoscopic cardial constriction in gastroesophageal reflux disease [J]. Medicine, 2018, 97(15): e0169.
|
| [55] |
Sumi K, Inoue H, Kobayashi Y, et al. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases [J]. Digestive Endoscopy, 2021, 33(3): 347-354.
|
| [56] |
Hedberg HM, Kuchta K, Ujiki MB. First Experience with Banded Anti-reflux Mucosectomy (ARMS) for GERD: Feasibility, Safety, and Technique (with Video) [J]. Journal of Gastrointestinal Surgery, 2019, 23(6): 1274-1278.
|
| [57] |
Garg R, Mohammed A, Singh A, et al. Anti-reflux mucosectomy for refractory gastroesophageal reflux disease: a systematic review and meta-analysis [J]. Endoscopy International Open, 2022, 10(6): E854-E864.
|
| [58] |
Mason RJ, Hughes M, Lehman GA, et al. Endoscopic augmentation of the cardia with a biocompatible injectable polymer (Enteryx) in a porcine model [J]. Surgical Endoscopy And Other Interventional Techniques, 2002, 16(3): 386-391.
|
| [59] |
Frazzoni M. Laparoscopic fundoplication for gastroesophageal reflux disease [J]. World Journal of Gastroenterology, 2014, 20(39): 14272.
|
| [60] |
Humphries LA, Hernandez JM, Clark W, et al. Causes of dissatisfaction after laparoscopic fundoplication: the impact of new symptoms, recurrent symptoms, and the patient experience [J]. Surgical Endoscopy, 2013, 27(5): 1537-1545.
|
| [61] |
Lee Y, Tahir U, Tessier L, et al. Long-term outcomes following Dor, Toupet, and Nissen fundoplication: a network meta-analysis of randomized controlled trials [J]. Surgical Endoscopy, 2023, 37(7): 5052-5064.
|
| [62] |
Li S, Jiao S, Zhang S, et al. Revisional surgeries of laparoscopic sleeve gastrectomy [J].
|
| [63] |
Diabetes Metab Syndr Obes, 2021, 14: 575-588.
|
| [64] |
Ganam S, Tang R, Sher T, et al. Quality of life in patients undergoing revisional bariatric surgery: from sleeve gastrectomy to Roux-en-Y gastric bypass [J]. Obesity Surgery, 2024, 34(3): 997-1003.
|
| [65] |
Lee MH, Almalki OM, Lee WJ, et al. Outcomes of laparoscopic revisional conversion of sleeve gastrectomy to Roux-en-Y gastric bypass: Different strategies for obese and non-obese Asian patients [J]. Asian Journal of Surgery, 2023, 46(2): 761-766.
|
| [66] |
Rayman S, Assaf D, Azran C, et al. Sleeve gastrectomy failure-revision to laparoscopic one-anastomosis gastric bypass or Roux-n-Y gastric bypass: a multicenter study [J]. Obesity Surgery, 2021, 31(7): 2927-2934.
|